What are the possible viva question may be asked from Laryngoscope

Reading File
Finding Sources
Searching the Web

laryngoscope viva questions anesthesia surgery types blades

Finding Sources
Finding Sources
Reading Web Page

laryngoscope types blades uses mechanism components viva questions

Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
I now have comprehensive information from multiple authoritative anesthesia and emergency medicine textbooks. Let me compile a thorough viva answer set.

Viva Questions on Laryngoscope — Comprehensive Guide


1. What is a laryngoscope? What are its components?

A laryngoscope is an instrument used to visualize the larynx, particularly the glottic opening and vocal cords, primarily to facilitate endotracheal intubation.
Components:
  • Handle — holds the power source (batteries); held in the left hand during use
  • Blade — inserted into the mouth; comes in curved (Macintosh) and straight (Miller) designs
  • Light source — either a conventional bulb at the tip of the blade or a fibre-optic system transmitting light from the handle
  • Flange — along the left side of the blade; used to sweep the tongue to the left
  • Hook/locking mechanism — connects blade to handle at a right angle (when engaged, activates the light)

2. What are the types of laryngoscope blades?

Curved Blades

BladeKey Feature
MacintoshMost common curved blade; tip placed in the vallecula; lifts epiglottis indirectly via the hyoepiglottic/glossoepiglottic ligament
McCoyModified Macintosh with a hinged, lever-controlled tip; useful in anterior airways and difficult intubations
Bizzarri-GiuffridaVariation of Macintosh with modified flange

Straight Blades

BladeKey Feature
MillerMost common straight blade; tip goes under the epiglottis, lifting it directly
WisconsinSimilar to Miller but flange expands more distally; may increase visual field
Guedel, Soper, FlaggOther straight blade variations
(Roberts and Hedges' Clinical Procedures in Emergency Medicine; Barash Clinical Anesthesia, 9e)

3. What is the difference between Macintosh and Miller blades?

FeatureMacintosh (Curved)Miller (Straight)
Tip placementValleculaUnder the epiglottis
Epiglottis liftingIndirect (via hyoepiglottic ligament)Direct (compresses epiglottis against tongue base)
Preferred inUncomplicated adult intubationsPediatric patients; anterior larynx; long floppy epiglottis
Tongue retractionBetter (wider blade keeps tongue out of view)Less effective
Dental traumaLess likelyMore likely (especially upper incisors)
Laryngospasm riskLowerHigher (stimulates superior laryngeal nerve on undersurface of epiglottis)
Esophageal advancementLess commonCan inadvertently enter esophagus
ETT passage spaceMore room through oropharynxLess room; bulb at tip may obstruct view
(Roberts and Hedges' Clinical Procedures in Emergency Medicine; Miller's Anesthesia, 10e)

4. What is the technique of direct laryngoscopy?

  1. Patient in "sniffing position" (head extended, neck flexed) — aligns oral, pharyngeal, and laryngeal axes
  2. Laryngoscope held in the left hand
  3. Blade inserted from the right side of the mouth, avoiding teeth and lips
  4. Tongue swept to the left and compressed into the mandibular space
  5. Macintosh: advance tip into the vallecula → lift in an anterior-caudad direction
  6. Miller: advance tip under the epiglottis → directly lift
  7. Lift is directed at 45° toward the junction of the opposite wall and ceiling — never lever on the teeth
  8. Vocal cords visualized → ETT passed under direct vision

5. What is the "sniffing position"? Why is it important?

The sniffing position involves neck flexion + head extension at the atlanto-occipital joint. It aligns the three axes needed for direct laryngoscopy:
  • Oral axis
  • Pharyngeal axis
  • Laryngeal axis
In obese patients, the EAM-SN position (external auditory meatus aligned with sternal notch) is used — achieved by ramping with wedge under the scapula/shoulders, which moves the chest mass away and creates space for laryngoscope handle manipulation.

6. What are the blade sizes?

BladeSizes
Macintosh1 (small child), 2 (child), 3 (average adult), 4 (large adult)
Miller0 (premature/neonate), 1 (infant/young child), 2 (child/small adult), 3 (average adult)
Infants and young children are best intubated with a straight (Miller) blade because their epiglottis is U-shaped, floppy, and sits more cephalad and anteriorly. Miller 0 is used for premature neonates.

7. What are video laryngoscopes? Name types.

Video laryngoscopes (VL) use a camera on the blade tip to provide an indirect view on a screen, without requiring direct line-of-sight alignment.
Common devices:
  • GlideScope (Verathon) — hyperangulated blade; most studied
  • C-MAC (Karl Storz) — blade similar to Macintosh; allows both direct and video laryngoscopy; instructors can see the operator's view
  • McGrath Series 5 (Teleflex)
  • Airtraq — optical laryngoscope with channel for ETT
Advantages over DL:
  • Higher first-pass success in difficult airways
  • No strict axis alignment needed
  • Teaching tool (assistants can view simultaneously)
Disadvantages:
  • May fail if lens obscured by blood/vomitus — avoid in cases with copious emesis
  • Device failure possible
  • Skill set slightly different from DL
(Tintinalli's Emergency Medicine; Roberts and Hedges'; Morgan & Mikhail Clinical Anesthesiology, 7e)

8. What are the indications and contraindications of direct laryngoscopy?

Indications:
  • Any situation requiring a definitive emergency airway
  • Routine and difficult elective intubations
  • RSI (rapid sequence intubation)
Relative contraindications:
  • Limited mouth opening (trismus, TMJ ankylosis)
  • Upper airway distortion or swelling (epiglottitis, angioedema, abscess)
  • Severe kyphosis/cervical spine instability
  • Copious blood or secretions (consider video laryngoscopy or awake fibreoptic instead)

9. What is the BURP maneuver? What is ELM?

  • BURP (Backward, Upward, Rightward Pressure) — applied externally on the thyroid cartilage; improves glottic visualization during laryngoscopy
  • ELM (External Laryngeal Manipulation) — operator's own right hand applies external pressure on the larynx to optimize the view, then an assistant maintains that pressure
  • Cricoid pressure (Sellick's maneuver) — backward pressure on cricoid ring to compress oesophagus; used to prevent regurgitation during RSI (its routine use is now debated)

10. What is the light source in a laryngoscope?

  • Conventional/Standard: Small bulb at the tip of the blade; can be replaced; may slightly hamper vision
  • Fibre-optic: Light transmitted via optical fibres from the handle; provides brighter, shadow-free illumination; no bulb at tip; easier sterilization
  • LED: Modern option; brighter, longer lasting
  • Studies (Levitan) show that blade brightness is frequently inadequate — only 24% of Macintosh blades in one ED survey met the brightness needed for fine inspection. The G-Mac (German design) provides the best brightness; A-Mac (American) the least.

11. What nerve is at risk with straight blade laryngoscopy?

The superior laryngeal nerve (branch of vagus) innervates the undersurface of the epiglottis. Straight blade insertion under the epiglottis can stimulate this nerve, increasing the risk of laryngospasm.

12. What is the Cormack-Lehane grading?

A grading system for laryngoscopic view:
GradeView
IFull glottis visible
IIPartial glottis (only posterior commissure)
IIIOnly epiglottis visible
IVNo laryngeal structures visible
Grade III–IV = difficult laryngoscopy.

13. What are common errors during laryngoscopy?

  • Blade placed under the middle of the tongue (tongue not swept left)
  • Tongue not pushed far enough to the left, obscuring glottis
  • Levering on upper teeth (risk of dental damage)
  • Advancing Miller blade into the oesophagus
  • Insufficient blade brightness
  • Incorrect patient positioning

14. What is a McCoy laryngoscope?

Modified Macintosh blade with a hinged, lever-controlled flexible tip. The lever at the handle allows elevation of the epiglottis independent of the overall lifting force — useful in:
  • Anterior airways
  • Patients with limited cervical spine movement
  • When Cormack-Lehane grade III is encountered with standard Macintosh

15. Macintosh blade — preferred in which situations?

  • Uncomplicated adult intubations (standard of care)
  • Small mouth (less room needed for ETT passage)
  • Patients with prominent upper teeth (less dental trauma)
  • When more space is needed to pass the ETT through the oropharynx

16. Miller blade — preferred in which situations?

  • Pediatric patients (especially < 2–6 years; superior POGO scores vs Macintosh)
  • Anterior larynx
  • Long, floppy epiglottis
  • Small mandibular space
  • Large incisors
  • Larynx fixed by scar tissue

17. What material are laryngoscope blades made of?

  • Stainless steel — durable, corrosion-resistant, most common for reusable blades
  • Chrome-plated brass — smooth finish, cost-effective
  • Plastic (disposable) — single-use; reduces cross-contamination; higher long-term cost

18. Disposable vs reusable blades — what are the considerations?

DisposableReusable
Infection controlBetter (no cross-contamination)Requires sterilization
CostHigher long-termLower over time
SterilizationNot neededMandatory (autoclave/chemical)
AvailabilitySingle-use stock neededMaintains with proper care

Summary Mnemonic: "MAC MILKS"

  • Macintosh — curved, vallecula, indirect epiglottis lift
  • Adult preferred for uncomplicated airways
  • C-MAC / GlideScope — video laryngoscopes
  • Miller — straight, under epiglottis, direct lift
  • Infants/pediatric — use straight (Miller)
  • Laryngospasm risk — with straight blade (SLN stimulation)
  • Keys: sniffing position, left hand, sweep tongue left, 45° lift
  • Sizes: Mac 1–4, Miller 0–3

Sources: Roberts and Hedges' Clinical Procedures in Emergency Medicine; Barash, Cullen, and Stoelting's Clinical Anesthesia, 9e; Miller's Anesthesia, 10e; Morgan & Mikhail's Clinical Anesthesiology, 7e; Tintinalli's Emergency Medicine

Disscus about goal directed fluid therapy in peri operative periods

Finding Sources
Searching PubMed

"goal-directed fluid therapy" AND perioperative

Searching the Web

goal directed fluid therapy perioperative 2024 guidelines GDFT

Reading File
Reading File
Reading Web Page

goal directed fluid therapy perioperative hemodynamic monitoring stroke volume fluid responsiveness

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
I now have comprehensive information from multiple authoritative textbooks and the latest POQI consensus guidelines. Let me compile a thorough discussion.

Goal-Directed Fluid Therapy (GDFT) in the Perioperative Period


1. Definition and Concept

Goal-Directed Fluid Therapy (GDFT) is a strategy of individualised fluid administration guided by dynamic hemodynamic parameters (rather than fixed volumes or static measures) to optimise cardiac preload, stroke volume, and ultimately tissue oxygen delivery — avoiding both hypovolaemia and fluid overload.
The concept originated from a 1983 study by Shoemaker et al., which demonstrated lower mortality in critically ill surgical patients when cardiac output and oxygen delivery were optimised to defined physiological goals.
"GDFT aims to avoid both hypovolemia and fluid excess, and it is the optimal approach for fluid administration in high-risk surgical patients." — Morgan & Mikhail's Clinical Anesthesiology, 7e

2. Physiological Basis — The Frank-Starling Curve

The cornerstone of GDFT is the Frank-Starling mechanism:
  • Increasing preload (ventricular filling) increases stroke volume — up to a plateau
  • On the steep ascending limb: patients are fluid-responsive (a bolus will increase stroke volume)
  • On the flat portion: additional fluid will not increase stroke volume but will cause fluid overload
GDFT aims to keep patients at the optimal point on the Frank-Starling curve — maximising stroke volume without causing excess.

3. Why Conventional Fixed-Volume Strategies Are Inadequate

ProblemConsequence
Too liberalFluid overload → pulmonary oedema, anastomotic leaks, wound infection, prolonged ileus, impaired mobilisation
Too restrictiveTissue hypoperfusion → AKI, organ failure
Static markers (CVP, PCWP) unreliableCVP is no longer recommended as a guide to fluid responsiveness
The RELIEF trial (largest RCT comparing restrictive ≤5 mL/kg/h vs liberal 8 mL/kg/h isotonic crystalloid in major noncardiac surgery) found:
  • AKI occurred more frequently in the restrictive group
  • Despite more fluid in the liberal group, 24-hour weight gain was < 2 kg with no worse outcomes
  • Target: positive fluid balance of 1–2 L at end of surgery using isotonic balanced crystalloid

4. Parameters Used in GDFT

A. Dynamic Parameters (Preferred — predict fluid responsiveness)

ParameterMechanismThreshold
Stroke Volume Variation (SVV)Respirophasic variation in SV during PPV; > 10–13% = fluid responsive> 10–13%
Pulse Pressure Variation (PPV)Variation in pulse pressure with ventilation; reflects LV preload dependence> 12–13%
Systolic Pressure Variation (SPV)Variation in systolic BP with respiration> 10%
Stroke Volume (SV)Direct measure via cardiac output monitorsBolus → ≥ 10% increase = positive response
"As volume is administered, pulse pressure variation decreases. Variation greater than 12–13% is suggestive of fluid responsiveness." — Morgan & Mikhail's Clinical Anesthesiology, 7e
POQI-11 Consensus (2023, London): Fluid responsiveness is best defined as a ≥10% increase in stroke volume in response to a rapidly administered (within 5 min) fluid bolus of ~250 mL. This is the primary means of determining fluid responsiveness.

B. Static Parameters (Less Reliable)

ParameterLimitation
CVPDoes not accurately reflect intravascular volume; no longer recommended for fluid responsiveness
PCWPReflects left-sided filling but affected by many confounders
Mean Arterial Pressure (MAP)Target ≥ 65 mmHg used as secondary goal
Urine outputDelayed response; affected by non-hypovolaemic causes

C. Limitations of Dynamic Parameters

Dynamic parameters (SVV, PPV) are only valid when:
  • Patient is mechanically ventilated with controlled PPV (not spontaneously breathing)
  • Sinus rhythm is present (atrial fibrillation/ectopy artificially elevates variation)
  • Tidal volume ≥ 8 mL/kg (low tidal volumes reduce reliability)
  • Abdomen is closed (open chest abolishes predictive value)
  • Deep sedation/paralysis present (patient not breathing out of sync with ventilator)

5. Monitoring Devices Used in GDFT

DeviceMethodInvasiveness
Esophageal DopplerMeasures descending aortic flow velocity → SVMinimally invasive
Pulse contour analysis (PiCCO, LiDCO, FloTrac/Vigileo)Arterial waveform analysis → continuous CO/SV/PPV/SVVMinimally invasive (arterial line)
Transesophageal echocardiography (TEE)Direct visualisation of LV filling and COSemi-invasive
Transthoracic echocardiography (TTE)Increasing ICU/OR use; non-continuousNon-invasive
Pulmonary artery catheter (PAC)Thermodilution CO, PCWPInvasive (now rarely used)
Pleth Variability Index (PVI)Non-invasive; photoplethysmographic waveform variationNon-invasive
Bioreactance (NICOM)Thoracic bioimpedance → CONon-invasive
"Studies of esophageal Doppler-guided strategies found no difference in intraoperative fluid or vasopressor totals, but beneficial effects were attributed to fluid administration at the right time." — Perioperative Fluid Management Review, BINASSS 2025

6. GDFT Protocol — Step-by-Step Algorithm

Baseline: IV balanced crystalloid 3 mL/kg/h
            ↓
   Assess fluid responsiveness
   (SVV/PPV > 12–13%? or SV < optimum?)
            ↓
        YES                    NO
         ↓                      ↓
Fluid bolus 250–500 mL      No additional fluid
(colloid or balanced         Consider vasopressor
 crystalloid)                 if MAP < 65 mmHg
         ↓
Re-assess: SV increase ≥ 10%?
    YES → repeat bolus        NO → stop fluids
                                   Add vasopressor/
                                   inotrope if needed
(POQI-11 Consensus Statement, 2023)
GDFT is not just fluids — vasopressors and inotropes are co-integrated:
  • Vasopressors (norepinephrine): correct anaesthesia-induced vasodilatation and prevent excess fluid administration
  • Inotropes: improve cardiac contractility when preload is optimised but CO remains low
  • Secondary goal: MAP ≥ 65 mmHg; Indexed oxygen delivery (DO₂I) > 600 mL/min/m²

7. Fluid Types Used in GDFT

Physiological NeedFluid of ChoiceVolume
Maintenance / insensible losses (closed abdomen)Balanced crystalloid (Lactated Ringer's / PlasmaLyte)0.5 mL/kg/h
Open abdomen evaporative lossesBalanced crystalloid1 mL/kg/h
Urine replacementBalanced crystalloidMeasured output
Blood lossIso-oncotic colloid (albumin 4–5%)1:1 ratio
Further preload deficit (intravascular)ColloidPer clinical estimation
Replacement ratios for blood loss:
  • Crystalloid: 1.5:1 (crystalloid : blood lost)
  • Colloid: 1:1
(Morgan & Mikhail's Clinical Anesthesiology, 7e — Table 48-3)

8. GDFT in the Context of ERAS (Enhanced Recovery After Surgery)

GDFT is a component of ERAS protocols, but evidence shows:
  • In a well-implemented ERAS pathway, GDFT does not confer additional benefit over conventional management in low-moderate risk patients
  • This is because ERAS already minimises fluid shifts (minimally invasive surgery, encouraged oral hydration during fasting, early postoperative oral intake)
  • GDFT guided by cardiac output monitoring is reserved for:
    • High-risk patients
    • Major surgical procedures
    • Expected blood loss > 1000 mL
"The use of goal-directed fluid therapy guided by cardiac output monitoring is appropriate in high-risk patients undergoing major surgical procedures in whom the expected blood loss is greater than 1000 mL." — Current Surgical Therapy, 14e

9. Perioperative Phases of GDFT

Preoperative

  • Identify high-risk patients (ASA ≥ 3, cardiac/renal comorbidities, major surgery)
  • Optimise fluid status (encourage oral fluids up to 2 h before surgery per enhanced fasting)
  • Establish baseline hemodynamics

Intraoperative

  • Baseline crystalloid infusion: 3–5 mL/kg/h
  • Guide boluses by dynamic parameters (SVV, PPV, SV response)
  • Replace blood loss per 1:1.5 (crystalloid) or 1:1 (colloid) ratios
  • Maintain MAP ≥ 65 mmHg; add vasopressors for vasodilatory hypotension
  • Target zero-to-slightly-positive fluid balance in ERAS cases

Postoperative

  • Continue hemodynamic monitoring in high-risk patients (ICU/HDU)
  • De-escalate monitoring as patient stabilises
  • Early oral intake encouraged in ERAS pathways
  • The "four-phase approach" (Resuscitation → Optimisation → Stabilisation → De-escalation) emphasises that fluid therapy is dynamic and must be frequently reassessed

10. Benefits of GDFT (Evidence Summary)

OutcomeEffect
Postoperative complicationsReduced (especially in high-risk patients)
Hospital length of stayShorter
Anastomotic leakageReduced
Acute kidney injuryReduced (vs restrictive strategies); preserved renal function (2024 prospective data)
Kidney transplant (delayed graft function)Reduced with GDFT (Klonarakis et al., 2024 — Meta-analysis, PMID 38335896)
Oncologic surgery outcomesImproved (Jin et al., 2025 — Meta-analysis, PMID 40305698)
Free flap surgeryReduced complications (Shamim et al., 2025 — Meta-analysis, PMID 41415860)
MortalityMixed — consistent mortality benefit not universally demonstrated
"Results of multiple meta-analyses suggest the benefits of GDFT may be less in optimisation of fluid responsiveness but more in optimising tissue and organ perfusion." — Perioperative Fluid Management Review, 2025
The combined strategy — optimising both fluid responsiveness AND cardiac output — offers the biggest clinical benefit.

11. Limitations and Controversies

  • Evidence is inconsistent across trials — heterogeneous protocols, variable patient populations
  • Less benefit in laparoscopic/robotic procedures with minimal physiological trespass
  • Dynamic parameters require specific conditions to be valid (see Section 4C)
  • Not all patients benefit — risk stratification is essential
  • Resource-intensive: requires advanced monitoring equipment and trained personnel
  • PVI (non-invasive pleth variability index) shows promise but evidence is still evolving (Felippe et al., 2025 — Meta-analysis, PMID 40778974)

12. Summary Table

FeatureGDFT
GoalOptimise SV/CO → maximise tissue O₂ delivery
Key principleFrank-Starling curve optimisation
Main parametersSVV, PPV, SV response to bolus
Fluid bolus thresholdSV increase ≥ 10% after 250 mL bolus
Baseline infusion3–5 mL/kg/h balanced crystalloid
Preferred fluidBalanced crystalloid (maintenance) + colloid (blood loss)
Monitoring devicesEsophageal Doppler, pulse contour analysis, TEE
Abandoned markerCVP (no longer recommended for fluid responsiveness)
Best candidatesHigh-risk patients; major surgery; expected blood loss > 1000 mL
In ERASBenefit attenuated; reserve for high-risk cases
AdjunctsVasopressors + inotropes when needed

Sources: Morgan & Mikhail's Clinical Anesthesiology 7e; Barash Clinical Anesthesia 9e; Miller's Anesthesia 10e; Current Surgical Therapy 14e; Roberts and Hedges' Clinical Procedures in Emergency Medicine; POQI-11 Consensus Statement on Goal-Directed Haemodynamic Therapy (2023); PMID 38335896, 40305698, 41415860, 40778974
This is a shared conversation. Sign in to Orris to start your own chat.